CD200 and breast carcinoma: Recent data from our laboratory suggests that sCD200 can also be detected in the serum of breast cancer and colonic cancer patients (unpublished data), consistent with the growing evidence that CD200 itself is reported to be overexpressed in a number of human cancers.